Alpha-1 Antitrypsin Deficiency: 10 Key Facts on Inherited Lung and Liver Disease

A complete guide to alpha-1 antitrypsin deficiency: genetics, early COPD, liver disease in children and adults, testing and treatment.

·

·

8–13 minutes

·

Edited by Joshua Adebanjo, RN

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency, often called AATD or alpha-1, is an inherited condition in which the body makes too little or a faulty form of a protein called alpha-1 antitrypsin.

This protein protects the lungs from damage by enzymes released during inflammation. Without enough of it, the lungs are damaged more easily, leading to emphysema at a young age, especially in smokers. Faulty protein can also build up in the liver, causing liver disease in babies, children and adults. It is one of the most under-diagnosed inherited conditions. This guide explains the signs, testing and treatment.

alpha-1 antitrypsin deficiency

Imagine a 41-year-old construction worker in Spain who has become increasingly breathless climbing stairs. He smoked for 15 years but stopped five years ago. He was told he had asthma, but inhalers haven’t helped much. At the clinic, the nurse notes that COPD at his age is unusual and arranges a blood test for alpha-1 antitrypsin. The level is very low, and genetic testing shows the ZZ type. His lung scans show emphysema. He starts pulmonary rehabilitation and, where available, augmentation therapy. His sister is tested and found to be a carrier.

What is alpha-1 antitrypsin deficiency?

Alpha-1 antitrypsin is made in the liver and travels in the blood to the lungs, where it neutralises an enzyme called neutrophil elastase. Without enough protection, this enzyme damages the delicate air sacs, causing emphysema.

The most common severe form is the PI*ZZ type, inherited from both parents. The Z protein folds abnormally and gets stuck in liver cells, which can damage the liver. People with one Z and one normal gene (MZ carriers) have mildly reduced levels and a modestly increased lung risk, especially if they smoke.

Alpha-1 antitrypsin deficiency affects about 1 in 2,000 to 5,000 people of European descent, but most are never diagnosed. It is less common in Asian and African populations. Smoking is the most important factor determining lung damage.

10 key facts about alpha-1 antitrypsin deficiency

  1. Alpha-1 antitrypsin deficiency is an inherited condition.
  2. It causes low levels of a lung-protecting protein.
  3. It can cause emphysema at a young age.
  4. Smoking greatly speeds lung damage.
  5. It can cause liver disease in babies and adults.
  6. Many people are misdiagnosed with asthma.
  7. A simple blood test detects it.
  8. Genetic testing identifies the type.
  9. Augmentation therapy is available in some countries.
  10. Family members should be tested.

Causes and risk factors

It is caused by:

  • Inheriting two faulty SERPINA1 genes (for example ZZ or SZ)
  • Carriers with one faulty gene have milder risk

Smoking, dust, fumes and repeated chest infections speed lung damage in people with the deficiency.

Symptoms and warning signs

Lung symptoms include:

  • Breathlessness on exertion
  • Wheezing
  • Chronic cough and phlegm
  • Repeated chest infections
  • Reduced exercise tolerance

Liver signs include jaundice in newborns, abnormal liver tests, swollen abdomen, easy bruising and, in adults, cirrhosis. Some people also develop a skin condition called panniculitis.

How alpha-1 antitrypsin deficiency is diagnosed

  • Blood test for alpha-1 antitrypsin level.
  • Genetic testing or phenotyping.
  • Lung function tests.
  • CT scan of the chest.
  • Liver tests and ultrasound.
  • Screening family members.

Treatment options

  • Stopping smoking completely.
  • Inhalers and pulmonary rehabilitation.
  • Vaccinations against flu, pneumonia and COVID-19.
  • Prompt treatment of chest infections.
  • Augmentation therapy (intravenous alpha-1 antitrypsin) in some countries.
  • Oxygen therapy if needed.
  • Lung volume reduction or transplant for severe disease.
  • Liver monitoring and transplant for liver failure.

Possible complications

  • Emphysema and COPD
  • Bronchiectasis
  • Cirrhosis and liver cancer
  • Panniculitis
  • Respiratory failure

Outlook

People who never smoke may have normal or near-normal life expectancy. Smokers with severe deficiency often develop emphysema in their 30s to 50s.

Early diagnosis and stopping smoking make the biggest difference.

Can it be prevented?

  • Never smoke.
  • Avoid dust, fumes and second-hand smoke.
  • Get vaccinated.
  • Limit alcohol to protect the liver.

Living with alpha-1 antitrypsin deficiency

  • Stay active.
  • Attend pulmonary rehabilitation.
  • Treat chest infections early.
  • Keep follow-up appointments.
  • Join patient support groups.

How families and communities can help

Siblings, children and parents should be offered testing.

Partners may be tested to clarify children’s risk.

Research and new developments

Research is testing new medicines to correct protein folding and gene therapies.

Studies of RNA-based treatments for liver disease are underway.

Around the world

Alpha-1 antitrypsin deficiency is most common in northern and western Europe.

Most people worldwide remain undiagnosed.

Nursing care and the role of nurses

Nurses help find and support people with alpha-1 antitrypsin deficiency.

  • Recognise early-onset COPD.
  • Arrange alpha-1 testing.
  • Support smoking cessation.
  • Deliver augmentation infusions.
  • Promote vaccination.
  • Coordinate family testing.

Who should be tested?

Testing is recommended for everyone with COPD, especially if it starts before age 45, occurs in people who smoked little or never, or runs in the family. It is also recommended for adults with unexplained liver disease, babies with prolonged jaundice, people with asthma that does not respond to treatment, bronchiectasis without a clear cause, and the relatives of anyone with the condition. A simple blood test measures the level, followed by genetic testing if low.

Augmentation therapy

Augmentation therapy involves weekly intravenous infusions of alpha-1 antitrypsin purified from donated blood. It raises blood and lung levels and has been shown to slow the loss of lung tissue in people with severe deficiency and emphysema. It is available in some countries and not others. Infusions can sometimes be given at home by a nurse or by the person after training.

Smoking and alpha-1

Smoking is by far the most important factor. In people with severe deficiency, smoking can lead to emphysema 10 to 20 years earlier than in non-smokers. Stopping smoking at any age slows lung decline. Avoiding second-hand smoke and workplace dust and fumes also helps.

Liver disease in children

Babies with alpha-1 antitrypsin deficiency may develop prolonged jaundice and abnormal liver tests. Most recover, but a small number develop serious liver disease needing transplant. Children with the condition should have regular liver checks.

Carriers

People with one faulty gene, such as MZ, usually have slightly reduced levels. They have a modestly increased risk of lung disease if they smoke, and some liver risk with other factors such as alcohol and obesity.

Pulmonary rehabilitation

Pulmonary rehabilitation combines exercise, breathing techniques and education. It improves breathlessness, exercise capacity and quality of life.

Living well

Joining an alpha-1 support organisation connects people with others, provides information and supports research.

Protecting your lungs every day

Beyond stopping smoking, everyday choices help preserve lung function. Avoid jobs and hobbies with heavy dust, fumes or chemical exposure, or use proper respiratory protection where they cannot be avoided. Keep up with yearly flu vaccination and recommended pneumococcal and COVID-19 vaccines, since chest infections can speed lung decline. Seek treatment promptly when phlegm changes colour, breathlessness worsens or fever develops; many people keep a rescue pack of antibiotics and steroids at home with a written action plan. Regular physical activity, such as walking, cycling or swimming, strengthens breathing muscles and improves stamina, and pulmonary rehabilitation teaches how to exercise safely. Maintaining a healthy weight, eating well and limiting alcohol protect both the lungs and the liver. Lung function tests every year or two help track progress and guide treatment decisions.

Talking to relatives

Because the condition is inherited, a diagnosis affects the whole family. Sharing results with siblings, parents and adult children allows them to be tested and, if needed, to make changes early, such as never smoking. Genetic counselling can help families understand results and plan conversations.

Myths and facts

Myth: Only heavy smokers get emphysema.
Fact: Alpha-1 can cause it early, even with little smoking.

Myth: It’s just asthma.
Fact: Alpha-1 is often misdiagnosed as asthma.

Myth: Carriers are always unaffected.
Fact: Carriers may have some increased risk.

Myth: Nothing can be done.
Fact: Stopping smoking and treatments help.

Frequently asked questions about alpha-1 antitrypsin deficiency

How is alpha-1 diagnosed?

With a blood test and genetic testing.

Is it inherited?

Yes.

Should my family be tested?

Yes.

Is there a cure?

No, but treatments slow damage.

Can children be affected?

Yes, mainly with liver problems.

Is augmentation therapy available everywhere?

No, access varies.

Can I drink alcohol?

Limit it to protect your liver.

When to seek help

  • Worsening breathlessness
  • Chest infection with fever
  • Yellow skin or eyes
  • Swollen abdomen
  • Coughing up blood

Key takeaways

  • Alpha-1 antitrypsin deficiency is an inherited condition.
  • Smoking greatly speeds lung damage.
  • Many people are misdiagnosed with asthma.
  • A simple blood test detects it.
  • Augmentation therapy is available in some countries.
  • Family members should be tested.

Looking after your emotional wellbeing

Any long or worrying health problem can affect mood, sleep, relationships and confidence. Feeling anxious, low, angry or isolated after a diagnosis of alpha-1 antitrypsin deficiency is common and understandable. Talking openly with family, friends, faith leaders or a support group can ease the load, and so can learning as much as you can about what to expect.

If low mood, hopelessness or worry last for more than two weeks, or if you have thoughts of harming yourself, tell your nurse or healthcare provider straight away. Emotional health is part of physical recovery, and support is available.

How to prepare for a clinic appointment

Before you see a nurse or healthcare provider, write down your symptoms, when they started and anything that makes them better or worse. Bring a list of all medicines, including herbal and traditional remedies, and any previous test results or clinic cards. If possible, bring a family member or friend to help you remember what is said.

During the appointment, ask the provider to explain anything you do not understand, and repeat the plan back in your own words. Before you leave, make sure you know what to do if symptoms get worse, when to return and who to contact with questions.

If cost, distance or work makes it hard to attend appointments, tell your nurse. Ask whether free or subsidised services, transport support, community health workers or phone follow-up are available in your area, so that practical problems do not stop you getting the care you need.

Planning ahead

Whether a health problem is short-lived or long term, a little planning makes care safer. Keep a folder or phone note with your diagnosis, medicines, allergies, recent test results and the contact details of your care team, and share it with a trusted family member. If you travel, carry enough medicines and a short letter describing your condition. Agree with your nurse or healthcare provider what to do if symptoms suddenly worsen and where to go out of hours, and review the plan whenever your treatment changes.

Support for carers

Caring for someone with a health condition can be rewarding but tiring. Carers should look after their own sleep, nutrition and health, ask relatives and friends for practical help, and ask about carer assessments, respite services and support groups in their area. Accepting help is a strength, not a failure, and it allows carers to keep supporting their loved one for longer.

Finding reliable health information

Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.

If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.

Questions to ask your nurse or healthcare provider

  • Should I be tested for alpha-1 antitrypsin deficiency?
  • What is my type?
  • Is augmentation therapy available?
  • How can I protect my lungs?
  • How often should my liver be checked?
  • Should my family be tested?

But isn’t COPD a disease of older smokers?

Usually, but COPD at a young age, or in someone who smoked little, may be caused by alpha-1 antitrypsin deficiency. A simple blood test can tell.

Your next step: If you have COPD, emphysema or difficult asthma, ask a nurse whether you’ve been tested for alpha-1 antitrypsin deficiency.

Related:

Sources: NHLBI: alpha-1 antitrypsin deficiency; Alpha-1 Foundation.

Joshua Ibukunoluwa Adebanjo

Founder & Editor-in-Chief

Joshua Ibukunoluwa Adebanjo

RN, RM, RPHN, BNSc (Obafemi Awolowo University)

Joshua is a registered nurse, midwife and public health nurse with clinical experience at Obafemi Awolowo University Teaching Hospitals Complex. He founded Nursing Media Network to give nurses worldwide trustworthy news, career guidance and a stronger public voice, and leads its editorial direction.

Full profile · Editorial policy · joshuadebanjo.com

Health information on Nursing Media Network is for education and does not replace advice from your own nurse or healthcare provider.

Leave a Reply

Discover more from Nursing Media Network

Subscribe now to keep reading and get access to the full archive.

Continue reading